_1576056721718.png?format=webp&height=120&width=120){kind=logo}
Enable Life Sciences - About the company
Enable Life Sciences is a funded company based in Cambridge (United States), founded in 2013 by Rachit Ohri. It operates as a Provides portfolio of biotech services. Enable Life Sciences has raised an undisclosed amount in funding. The company has 1957 active competitors, including 452 funded and 333 that have exited. Its top competitors include companies like Synthego, Antheia and Transcenta.
Company Details
Enables life science provides the portfolio of biotech services. Its services include management services for R & D and manufacturing units, analytical, medical device development, molecular biology, cell culture, in vivo evaluation and analysis among others. The company also developed the cell culture assay called actimmunity assay.
- Website
- enablelifesciences.com
- Email ID
- *****@enablelifesciences.com
- Phone Number
- +1 **********
- Registered Address
- Apartment 402, Tower 12, The Close South Nirvana Country, Near Artemis Hospital, Gurgaon, Gurgaon, Haryana, India, 122001
Key Metrics
Founded Year
2013
Location
Cambridge, United States
Stage
Funding Raised
Latest Funding Round
Investors
Ranked
663rd among 1957 active competitors
Employee Count
9 as on Jul 31, 2026
Legal entities associated with Enable Life Sciences
Enable Life Sciences is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ENABLE LIFE SCIENCES PRIVATE LIMITED CIN: U73100HR2013PTC064630 , India, Active | Oct 01, 2013 | 0 - ₹10 Cr (As on Mar 31, 2024) | - |
Sign up to download Enable Life Sciences' company profile
Enable Life Sciences's funding and investors
Enable Life Sciences has raised funding over 2 rounds. Its first funding round was on Apr 01, 2020. Its latest funding round was a Grant (prize money) round on Sep 15, 2023 for $*****. 1 investor participated in its latest round. Enable Life Sciences has 2 institutional investors.
Here is the list of recent funding rounds of Enable Life Sciences:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 15, 2023 | 3019941 | Grant (prize money) | 8063656 | 6634327 | 6230587 | 8139057 |
Apr 01, 2020 | 9749350 | Grant (prize money) | 9125492 | 1585654 | 1819496 |
Access funding benchmarks and valuations. Sign up today!View details of Enable Life Sciences's funding rounds and investors
Enable Life Sciences' founders and board of directors
Founder? Claim ProfileThe founders of Enable Life Sciences is Rachit Ohri. Rachit Ohri is the CEO of Enable Life Sciences.
Here are the details of Enable Life Sciences' key team members:
- Rachit Ohri: Founder & CEO of Enable Life Sciences and founder of 1 other company. Contact Info: 2 email addresses
View details of Enable Life Sciences's Founder profiles and Board Members
Enable Life Sciences' employee count trend
Enable Life Sciences has 9 employees as of Jul 26. Here is Enable Life Sciences's employee count trend over the years:
Uncover Enable Life Sciences' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Enable Life Sciences's Competitors and alternates
Top competitors of Enable Life Sciences include Synthego, Antheia and Transcenta. Here is the list of Top 10 competitors of Enable Life Sciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Synthego 2012, Redwood City (United States), Acquired | Developer of CRISPR-engineered cell and gene therapies | $460M | 71/100 | |
2nd | Antheia 2013, Palo Alto (United States), Series C | Genetically engineered yeast cells to produce medicinal products | $176M | 67/100 | |
3rd | Transcenta 2019, Suzhou (China), Public | Developer of antibody-based therapeutics | $205M | 66/100 | |
4th | _1530865304957.jpg?devicePixelRatio=2&height=30&width=30){kind=logo} Judges Scientific 2002, London (United Kingdom), Public | Acquisition and development of scientific instrument businesses | - | 65/100 | |
5th | Developer of antibody drug conjugates for the treatment of broad spectrum diseases | $195M | 65/100 | ||
6th | Korro Bio 2018, Cambridge (United States), Public | Provider of RNA editing technologies to develop genetic medicines for rare and prevalent diseases | $4M | 64/100 | |
7th | Fermentalg 2005, Libourne (France), Public | Innovating with algae for sustainable solutions in nutrition and environmental impact | $30.3M | 63/100 | |
8th | Microban 1994, Huntersville (United States), Acquired | Antimicrobial and odor control technologies for durable product protection and freshness | $64.6M | 63/100 | |
9th | Dewpoint Therapeutics 2018, Boston (United States), Series D | Developer of small molecule based therapeutics | $364M | 62/100 | |
10th | One Biosciences 2020, Paris (France), Series A | Developer of single-cell therapeutics solutions to treat multiple health disorders | $22.4M | 62/100 | |
663rd | _1576056721718.png?devicePixelRatio=2&height=30&width=30){kind=logo} Enable Life Sciences 2013, Cambridge (United States), Funding Raised | Provides portfolio of biotech services | - | 31/100 |
_1523881431192.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Enable Life Sciences's competitors? Click here to see the top ones
Enable Life Sciences's Investments and acquisitions
Enable Life Sciences has made no investments or acquisitions yet.
Reports related to Enable Life Sciences
Here is the latest report on Enable Life Sciences's sector:
Are you a Founder ?
FAQs about Enable Life Sciences
Explore our recently published companies
- ReFrame Engage - United States based, 2020 founded, Unfunded company
- Web Instant Messenger - Bolzano based, 2016 founded, Unfunded company
- Carekro - 2018 founded, Unfunded company
- Dnyhospitality - Unfunded company
- Doral SEO - Doral based, 2026 founded, Unfunded company
- EMJ - Italy based, 2026 founded, Unfunded company
